Skip to main content

Table 1 Drugs under investigation for CSU

From: Looking forward to new targeted treatments for chronic spontaneous urticaria

Study drug

Type of the drug

Clinicaltrials.gov identifier

Status

Quilizumab

Anti-IgE

NCT01987947

Completed

Ligelizumab

Anti-IgE

NCT02477332

Recruitment closed

AZD1981

PGD2 receptor antagonists

NCT02031679

Data processing

GSK2646264

Syk inhibitor

NCT02424799

Recruiting

Canakinumab

Anti-IL-1

NCT01635127

Unknown

Rilonacept

Anti-IL-1

NCT02171416

Recruiting

  1. Syk spleen tyrosine kinase, PGD2 prostagladin D2, IL-1 ınterleukin-1